Eligard side effects - from FDA reports

In this review, we analyze Eligard side effects by the time on the drug, gender and age of the people who have side effects while taking Eligard. The review is based on 6,014 people who have side effects while taking the drug from FDA, and is updated regularly.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our original studies have been referenced on 500+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO. On eHealthMe, you can research drugs and monitor them (see testimonials).


Eligard has active ingredients of leuprolide acetate. It is often used in prostate cancer. (latest outcomes from Eligard 6,039 users)

On Oct, 07, 2018

6,014 people who take Eligard are studied.

Number of reports submitted per year:

Eligard side effects.

Most common side effects over time *:

< 1 month:
  • Alanine aminotransferase increased
  • Hyperkalaemia (damage to or disease of the kidney)
  • Lipase increased
  • Neutropenia (an abnormally low number of neutrophils)
  • Ventricular fibrillation (abnormally irregular heart rhythm)
1 - 6 months:
  • Death
  • Terminal state (the transitional states between life and biological death)
  • Hot flush (sudden feelings of heat)
  • Prostate cancer metastatic
  • Prostatic specific antigen increased
6 - 12 months:
  • Death
  • Prostatic specific antigen increased
  • Prothrombin time abnormal
  • Weight increased
  • Hospitalisation

Click here to view more results or personalize the results to your gender and age

Most common side effects by gender *:

  • Focal nodular hyperplasia (tumour of the liver)
  • Weight decreased
  • Neoplasm progression (growth of tumour)
  • Visual impairment
  • Vomiting
  • Death
  • Prostatic specific antigen increased
  • Vomiting
  • Osteonecrosis of jaw (death of bone of jaw)
  • Pneumonia

Click here to view more results or personalize the results to your gender and age

Most common side effects by age *:

  • Xerosis (abnormal dryness of the skin or mucus membranes)
  • Focal nodular hyperplasia (tumour of the liver)
  • Psoriasis (immune-mediated disease that affects the skin)
  • Rash
  • Wheezing (a high-pitched whistling sound made while you breath)


Click here to view more results or personalize the results to your gender and age

* Approximation only. Some reports may have incomplete information.

FDA reports used in this study

You are not alone:

Related studies

All Eligard side effects from A to Z

a b c d e f g h i j k l m n o p q r s t u v w x y z

On eHealthMe, Eligard (leuprolide acetate) is often used to treat prostate cancer. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:

Related publications that referenced our studies

Recent updates

Recent general studies
Recent personal studies

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.